Dopamine D2 receptor SPECT imaging: Basicin vivo characteristics and clinical applications of123I-IBZM in humans

Author:

Toyama Hiroshi,Ichise Masanori,Ballinger James R.,Fornazzari Luis,Kirsh Joel C.

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference43 articles.

1. Verhoeff NPLG: Pharmacological implications for neuroreceptor imaging.Eur J Nucl Med 18: 482–502, 1991

2. Baron JC, Mazière B, Loc’h C, et al: Loss of striatal [76Br] bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy.J Cereb Blood Flow Metab 11: 220–228, 1991

3. Budinger TF: Advances in emission tomography: Quo vadis? [Editorial]J Nucl Med 31: 628–631, 1990

4. Kung HF, Pan S, Kung MP, et al:In vitro andin vivo evaluation of [123I]IBZM: A potential CNS D-2 dopamine receptor imaging agent.J Nucl Med 30: 88–92, 1989

5. Brücke T, Tsai YF, Mclellan C, et al:In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): A potential imaging ligand for D-2 dopamine receptors in SPECT.Life Sci 42: 2097–2104, 1988

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3